Biosynthesis of prodigiosin by white strains of Serratia marcescens isolated from patients

Insights

Most clinical Serratia marcescens strains do not produce prodigiosin pigment. Supplementation with precursors like 4-methoxy-2,2'-bipyrrole-5-carboxyaldehyde (MBC) and 2-methyl-3-amylpyrrole (MAP) revealed that only a few strains synthesize true prodigiosin.

Area of Science:

  • Microbiology
  • Biochemistry

Background:

  • Serratia marcescens is an opportunistic pathogen.
  • Clinical isolates of S. marcescens typically do not produce prodigiosin, a red pigment.

Purpose of the Study:

  • To investigate pigment production in white S. marcescens strains from patients.
  • To determine if MBC supplementation induces prodigiosin synthesis.

Main Methods:

  • Studied 65 white S. marcescens strains from patients.
  • Classified strains based on pigment response to 4-methoxy-2,2'-bipyrrole-5-carboxyaldehyde (MBC).
  • Analyzed synthesized pigments using acid-base treatments and spectral analysis; tested response to MBC plus 2-methyl-3-amylpyrrole (MAP).

Main Results:

  • Most strains (class 1 & 2) produced non-prodigiosin pigments or no pigment with MBC alone.
  • Class 3 strains produced blue pigments with MBC.
  • Only class 3 strains synthesized characteristic prodigiosin when supplied with both MBC and MAP.

Conclusions:

  • Pigments formed by most S. marcescens clinical isolates in response to MBC are not prodigiosin.
  • Prodigiosin synthesis in these strains requires both MBC and MAP precursors.

Related Concept Videos

Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...